Kicking off our 2024 Webcast Program with a conversation with Dr. Carl June, a pioneer in the field of CAR T-Cell Therapy.
Don’t forget to submit your question in the registration form. This is a fantastic chance to get answers on topical questions in the CAR-T space from a pioneer and leader in the field.
In our first Webcast, Dr. Carl June and Mr. Christopher Ung will discuss their insights into the challenges and future trends in the CAR T-cell therapy space today, including:
Dr. Carl June is the Richard W. Vague Professor in Immunotherapy in the Perelman School of Medicine at the University of Pennsylvania. In 2011, his research team published a new therapy treating patients with their own genetically engineered T-cells. Dr. June currently sits on CellCarta’s Scientific Advisory Board.
Mr. Christopher Ung has served in the companion diagnostics field since its inception and is one of the original pioneers of the personalized medicine field. He currently leads the development and execution of CellCarta’s strategic and business initiatives as Chief Scientific Business Officer.
Our new Webcast series features in-depth conversations with thought leaders in precision therapeutics. Join our speakers as they engage in insightful fireside chat-style discussions on a variety of topics in this dynamic space.
Subscribe to our newsletter to not miss our future Webcasts!